scholarly journals Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non–ST-Segment Elevation Acute Coronary Syndromes

2005 ◽  
Vol 165 (16) ◽  
pp. 1870 ◽  
Author(s):  
Matthew T. Roe ◽  
Eric D. Peterson ◽  
Yun Li ◽  
Charles V. Pollack ◽  
Robert H. Christenson ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Cardiac Troponin ◽  
Acute Coronary Syndromes ◽  
Troponin Level ◽  
Adherence To Guidelines ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes

scholarly journals Value of continuous risk stratification early after admission in non-ST-segment elevation acute coronary syndromes

2002 ◽  
Vol 39 ◽  
pp. 316
Author(s):  
Jorge M. Ferreira ◽  
Carlos Aguiar ◽  
Ana Timóteo ◽  
Katya Reis Santos ◽  
Ricardo Seabra-Gomes
Keyword(s):  
Risk Stratification ◽  
Acute Coronary Syndromes ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes

scholarly journals The IFCC Clinical Application of Cardiac Biomarkers Committee’s Appraisal of the 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation: Getting Cardiac Troponin Right

2020 ◽  
Author(s):  
Fred S Apple ◽  
Paul O Collinson ◽  
Peter A Kavsak ◽  
Richard Body ◽  
Jordi Ordóñez-Llanos ◽  
...  
Keyword(s):  
Clinical Application ◽  
Cardiac Troponin ◽  
Acute Coronary Syndromes ◽  
Clinical Chemistry ◽  
Cardiac Biomarkers ◽  
International Studies ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes ◽  
Esc Guidelines

Abstract The Committee on the Clinical Application of Cardiac Biomarkers (C-CB) of the International Federation of Clinical Chemistry (IFCC) represents international groups from laboratory medicine, cardiology and emergency medicine involved in providing global educational guidance pertaining to the analytical and clinical applications of cardiac biomarkers. For that reason, most of the members are involved with national and international studies and trials pertaining to high sensitivity (hs) cardiac troponins I and T (cTnI and cTnT) (1-3). Although the recently published ‘2020 European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation’ present some topics very well, the current special report was developed to delineate our specific concerns regarding the ESB guidance for the use of hs-cardiac troponin (hs-cTn) (4).

Sign in / Sign up

Export Citation Format

Share Document